• Here’s the dividend forecast out to 2028 for NAB shares

    Different Australian dollar notes in the palm of two hands, symbolising dividends.

    National Australia Bank Ltd (ASX: NAB) shares could be a pleasing passive income option, depending on what dividends the ASX bank share ends up paying.

    Banks like NAB have can deliver a solid dividend yield thanks to its fairly low price/earnings (P/E) ratio and generous dividend payout ratio.

    NAB’s profit is fairly consistent due to the nature of banking. Borrowers repay their loans every month, providing NAB with resilient cash flow.

    Let’s take a look at what experts expect for NAB’s dividend in the coming years.

    FY26

    We’re close to the end of the 2026 financial year for NAB, which ends in September 2026. The last we heard from the ASX bank share was the three months to 30 June 2026.

    Its FY26 third quarter saw the bank generate statutory net profit after tax (NPAT) of $1.81 billion, an increase of 32% compared to the quarterly average of the FY26 first half.

    Revenue grew by 2% compared to the first-half FY26 quarterly average, and 5% year-over-year. Cash earnings of $1.83 billion were up 4% year-over-year, and 2% compared to the FY26 first-half quarterly average.

    It’s not a lot of growth, but it’s growth nonetheless at a difficult time.

    Its credit impairment charges came to $299 million. Within that, its collective provision charges were $119 million, driven by business lending volume growth and a deterioration in performing book asset quality. It’s something to keep an eye on amid higher interest rates and potential stress related to the Middle East conflict.

    According to the projection on CMC Invest, NAB could pay an annual dividend per NAB share of $1.70, which would be the same as FY25.

    FY27

    The 2027 financial year could see an improvement in the bank’s financials, according to the earnings and dividend projections. Forecasts are not guaranteed to happen of course, but I think any growth during the current period would be impressive.

    According to the projection on CMC Invest, the ASX bank share is forecast to slightly increase its annual payout to $1.705 per NAB share.

    FY28

    The final year of this series of projections could be the best of all for shareholders of National Australia Bank.

    The forecast on CMC Invest suggests that the business could accelerate the growth of its dividend, taking the annual payout to $1.73 per NAB share.

    At that potential level, the ASX bank share could deliver a grossed-up dividend yield of 6.4%, including franking credits, at the time of writing.

    The post Here’s the dividend forecast out to 2028 for NAB shares appeared first on The Motley Fool Australia.

    Should you invest $1,000 in National Australia Bank right now?

    Before you buy National Australia Bank shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and National Australia Bank wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • 2 ASX shares highly recommended to buy: Experts

    Two brokers analysing the share price with the woman pointing at the screen and man talking on a phone.

    The ASX share market is always throwing up opportunities for us to consider. Sometimes it’s a great update or a lower share price that reveals the opportunity.

    I’m going to look at two ASX shares that are very positively rated by experts, with lots of buy calls on the stocks.

    When one expert thinks a business is a buy, it could be interesting idea. When there are numerous buy ratings, that could be a clear opportunity.

    Netwealth Group Ltd (ASX: NWL)

    Netwealth describes itself as a financial services company. It provides a number of services including superannuation (accumulation and retirement income products), investor-directed portfolio services for self-managed super and non-super investments, managed accounts, managed funds, SMSF admin services and non-custodial admin and reporting services.

    According to CMC Invest, there have been 12 ratings on the business within the last three months. Nine of those analyst calls were a buy and three were a hold. The average price target of those 12 ratings was $27, implying a possible rise of 43% over the next year, from where it is at the time of writing.

    The company continues to win more funds under administration (FUA), grow market share and win more advisors.

    The ASX share reported that in FY26, total income grew 20.6% to $391.1 million, operating profit (EBITDA) rose 18% to $192.9 million, and net profit after tax (NPAT) climbed 16.2% to $135.4 million.

    Netwealth expects FY27 FUA net inflows of between $18 billion to $20 billion, an increase of between 17% to 30% compared to FY26. It also recently announced the $20 million acquisition of Paradino, a leading AI-enabled advice workflow and automation platform for financial advisors.

    Paladin Energy Ltd (ASX: PDN)

    The other ASX share I’ll highlight is Paladin Energy, a uranium producer with 75% ownership of the Langer Heinrich Mine in Namibia.

    It’s also progressing development of the Tier-1, high grade and shallow Patterson Lake South project in northern Saskatchewan. The ASX share has a portfolio of exploration assets within the province’s highly prospective Athabasca Basin and also at the Michelin project in Newfoundland and Labrador.

    On top of that, it owns uranium exploration assets in Queensland and Western Australia.

    According to CMC Invest, there have been 13 analyst ratings on the business within the last three months. Ten of those analyst calls were a buy, one was a hold and two were a sell. The average price target of $13.55 suggests a possible annual rise of 33% from where it is at the time of writing.

    FY26 was a strong year for the business. Its average realised (sold) price rose 7% to US$70 per pound, revenue grew 71% to US$304 million, gross profit improved $78.3 million to $52.2 million and operating cash flow surged $41.5 million to $37.7 million.

    As we can see, its financials are significantly improving and the company is working unlocking further uranium production in the future.

    The post 2 ASX shares highly recommended to buy: Experts appeared first on The Motley Fool Australia.

    Should you invest $1,000 in Paladin Energy right now?

    Before you buy Paladin Energy shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Paladin Energy wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Netwealth Group. The Motley Fool Australia has positions in and has recommended Netwealth Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • How I’d build a $50,000 ASX share portfolio today

    Businessman planning and analysing investment data.

    If I were starting fresh with $50,000 to invest today, I would keep things fairly simple.

    I would want a portfolio with exposure to different parts of the economy, some global diversification, and businesses I would be comfortable holding for many years.

    Rather than spreading the money across dozens of investments, I would use one broad exchange-traded fund (ETF) as a foundation and build around it with a handful of ASX shares I particularly like.

    Here is how I would allocate the full $50,000.

    Vanguard MSCI Index International Shares ETF (ASX: VGS)

    I would start with $12,000 in the VGS ETF.

    The fund gives investors exposure to a large portfolio of companies across developed markets outside Australia, including major businesses from the United States, Europe, and Asia.

    For me, this provides an important diversification base. Instead of relying entirely on the Australian economy and a handful of individual companies, part of the portfolio would be spread across over a thousand global businesses and numerous industries.

    That would make the Vanguard MSCI Index International Shares ETF my largest single allocation.

    Commonwealth Bank of Australia (ASX: CBA)

    I would put $8,000 into Commonwealth Bank.

    CBA gives the portfolio exposure to Australia’s banking sector through a business with leading positions across home lending, deposits, and digital banking.

    I also like the combination of earnings resilience and dividends it can bring to a long-term portfolio.

    The valuation can become stretched at times, so I would not want to make the position too large. But I would still want CBA as part of my starting portfolio.

    BHP Group Ltd (ASX: BHP)

    Another $8,000 would go into BHP shares.

    The mining giant adds exposure to commodities including iron ore and copper, providing a source of earnings quite different from CBA and the global companies held through the VGS ETF.

    I am particularly positive on copper’s long-term outlook as investment in power networks, renewable energy, data centres, and electrification drives demand.

    BHP would also add some dividend income to the portfolio, although payouts will naturally move with commodity conditions.

    CSL Ltd (ASX: CSL)

    I would allocate $6,000 to CSL shares.

    The healthcare giant has global operations across plasma therapies, vaccines, and specialised medicines.

    After a difficult period for the shares, I think there is an attractive opportunity if CSL can continue improving earnings and margins over the coming years.

    It also gives the portfolio another source of growth that is less dependent on Australian economic conditions.

    ResMed Inc. (ASX: RMD)

    I would put $6,000 into ResMed shares.

    The company is a global leader in devices and masks used to treat sleep apnoea, giving it exposure to a substantial healthcare market.

    For example, management estimates that there are over 1 billion sufferers of sleep apnoea globally, with the majority undiagnosed.

    As a result, ResMed is the type of high-quality global business I would be comfortable owning for many years.

    Wesfarmers Ltd (ASX: WES)

    I would allocate $5,000 to Wesfarmers shares.

    Through businesses including Bunnings, Kmart, and Officeworks, Wesfarmers provides exposure to some of Australia’s strongest retail operations.

    I also like its history of disciplined capital allocation and willingness to invest across different industries when opportunities arise.

    That makes it a strong long-term portfolio holding in my view.

    Xero Ltd (ASX: XRO)

    Finally, I would invest $5,000 in Xero shares.

    Its accounting software is deeply embedded in the operations of small businesses and accountants, while its international presence gives the company plenty of room to grow.

    This would be one of the portfolio’s more growth-focused positions and provide additional technology exposure alongside the global holdings inside the VGS ETF.

    Foolish takeaway

    If I were investing $50,000 from scratch, this is the sort of balance I would want.

    The VGS ETF would give me broad global diversification from day one, while CBA, BHP, CSL, ResMed, Wesfarmers, and Xero would let me put additional money behind individual businesses I believe can perform well over the long term.

    I think that gives the portfolio a strong foundation without overcomplicating it.

    The post How I’d build a $50,000 ASX share portfolio today appeared first on The Motley Fool Australia.

    Should you invest $1,000 in BHP Group right now?

    Before you buy BHP Group shares, consider this:

    Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and BHP Group wasn’t one of them.

    The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    And right now, Scott thinks there are 5 stocks that may be better buys…

    * Returns as of 1 August 2026

    .custom-cta-button p {
    margin-bottom: 0 !important;
    }

    More reading

    Motley Fool contributor Grace Alvino has positions in CSL, Commonwealth Bank Of Australia, and Wesfarmers. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, ResMed, Wesfarmers, and Xero. The Motley Fool Australia has positions in and has recommended ResMed and Xero. The Motley Fool Australia has recommended BHP Group, CSL, Vanguard Msci Index International Shares ETF, and Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

  • Waiting for coronavirus stimulus check? Direct deposit information is due Wednesday, IRS says

  • CytomX Therapeutics, Inc. Just Beat Earnings Expectations: Here’s What Analysts Think Will Happen Next

  • Europe Stocks Could Be Spooked on Second Wave: Rathbones

  • Analysts Just Made A Huge Upgrade To Their Everspin Technologies, Inc. (NASDAQ:MRAM) Forecasts